Americas ETF News
you are currently viewing:REX Shares Launches REX Peptide ETF (PEPT)October 14, 2026-New thematic ETF targets the full peptide value chain: the drug developers, manufacturers, delivery specialists, and consumer brands behind today's GLP-1 treatments and the pipeline forming beyond obesity, in one globally diversified trade.
PEPT holds the companies that develop, manufacture, deliver, and commercialize peptide-based products, expanding investor exposure beyond the two drugmakers that dominate today’s GLP-1 market. It is REX's third thematic ETF, following the REX Drone ETF (DRNZ) and the REX AI Chipmaking ETF (CHIP). Peptides are the body's own signaling molecules, re-engineered into precise, scalable medicines. They are the technology behind today’s GLP-1 treatments and a growing pipeline of therapies well beyond obesity, spanning metabolic disease, cardiovascular indications, oncology, and rare disease. Most portfolios hold peptide exposure only through Eli Lilly and Novo Nordisk. Source: REX Shares |
Timothy Partners, Ltd. Names Brian Mumbert CEO
October 6, 2026-20-year Timothy Partners veteran succeeds founder Art Ally as CEO
Timothy Partners, Ltd., investment adviser to the Timothy Plan family of funds, has named Brian Mumbert chief executive officer, succeeding Timothy Plan founder Art Ally. Mumbert becomes only the second CEO in the firm's 32-year history.
Tradr Announces Liquidation of CPNX, NXPX, PONX, SMZ & TSEU
October 6, 2026-Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced that a plan of liquidation has been approved for the following funds:
Tradr 2X Long CPNG Daily ETF (Cboe: CPNX)
Tradr 2X Long PONY Daily ETF (Cboe: PONX)
Advisors Asset Management ETF Suite Surpasses $1 Billion in Assets Under Management
October 6, 2026-Advisors Asset Management (AAM), a leading investment solutions provider, today announced that as of October 1, 2026, its exchange traded fund (ETF) suite has surpassed $1 billion in assets under management (AUM).
Logan Capital Launches International ETF (NYSE: LCIV)
October 6, 2026--The fund offers investors access to high-conviction international equity exposure based on a 20-year track record in developed markets
Logan Capital, an independent, privately owned Registered Investment Advisor, has launched its second exchange-traded fund (ETF), the Logan Capital International ETF (NYSE: LCIV). The ETF follows Logan Capital's International Dividend ADR separately managed account (SMA) strategy, which has been managed continuously since 2006.
